08.30 – 10.15
The Canadian guidelines
J. Healey/ Hamilton, Canada
The NICE guidelines
I. Savelieva / London, UK
The Asia Pacific Heart Rhythm Society guidelines
H.F. Tse / Hong Kong, China
11.00 – 13.00
Ablation of AF and left sided atrial arrhythmias
A. Natale
Ablation of right sided ventricular tachycardias
P. Della Bella / Milan, Italy
13.00 – 14.30
Patients undergoing AF ablation
S. Themistoclakis/ Venice-Mestre, Italy
Patients undergoing cardioversion
R. Cappato / Rozzano, Italy
14.30 – 16.30
CKD and atrial fibrillation: warfarin, NOAC or nothing?
T. Potpara / Belgrade, Serbia
End-stage renal disease and other arrhythmias: what relationships and clinical implications?
C.J. Ferro / Birmingham, UK
17.00 – 19.00
Weighing the risk of stroke versus the risk of bleeding: which AF patients should be anticoagulated?
A.L. Waldo/ Cleveland, USA
Atrial fibrillation detected on routine device follow-up: when is anticoagulation indicated?
J. Healey / Hamilton, Canada
Does AF ablation lower stroke risk?
H. Calkins/ Baltimore, USA
Appendage occlusion devices: do they have a role?
R.D. Berger / Baltimore, USA
Intracerebral microbleeds: what are they? And should we care?
T.J. Bunch/ Murray, USA